Ionis Pharmaceuticals Share Holder Equity 2010-2025 | IONS

Ionis Pharmaceuticals share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  • Ionis Pharmaceuticals share holder equity for the quarter ending March 31, 2025 was $0.476B, a 60.44% increase year-over-year.
  • Ionis Pharmaceuticals share holder equity for 2024 was $0.588B, a 52.15% increase from 2023.
  • Ionis Pharmaceuticals share holder equity for 2023 was $0.387B, a 32.5% decline from 2022.
  • Ionis Pharmaceuticals share holder equity for 2022 was $0.573B, a 25.77% decline from 2021.
Ionis Pharmaceuticals Annual Share Holder Equity
(Millions of US $)
2024 $588
2023 $387
2022 $573
2021 $772
2020 $743
2019 $1,685
2018 $1,187
2017 $365
2016 $100
2015 $201
2014 $258
2013 $378
2012 $183
2011 $171
2010 $245
2009 $302
Ionis Pharmaceuticals Quarterly Share Holder Equity
(Millions of US $)
2025-03-31 $476
2024-12-31 $588
2024-09-30 $662
2024-06-30 $264
2024-03-31 $297
2023-12-31 $387
2023-09-30 $315
2023-06-30 $428
2023-03-31 $487
2022-12-31 $573
2022-09-30 $594
2022-06-30 $625
2022-03-31 $710
2021-12-31 $772
2021-09-30 $531
2021-06-30 $583
2021-03-31 $681
2020-12-31 $743
2020-09-30 $1,606
2020-06-30 $1,595
2020-03-31 $1,570
2019-12-31 $1,685
2019-09-30 $1,498
2019-06-30 $1,457
2019-03-31 $1,387
2018-12-31 $1,187
2018-09-30 $840
2018-06-30 $817
2018-03-31 $387
2017-12-31 $365
2017-09-30 $398
2017-06-30 $216
2017-03-31 $202
2016-12-31 $100
2016-09-30 $140
2016-06-30 $111
2016-03-31 $158
2015-12-31 $201
2015-09-30 $245
2015-06-30 $300
2015-03-31 $276
2014-12-31 $258
2014-09-30 $345
2014-06-30 $367
2014-03-31 $374
2013-12-31 $378
2013-09-30 $401
2013-06-30 $401
2013-03-31 $201
2012-12-31 $183
2012-09-30 $170
2012-06-30 $154
2012-03-31 $151
2011-12-31 $171
2011-09-30 $187
2011-06-30 $212
2011-03-31 $228
2010-12-31 $245
2010-09-30 $254
2010-06-30 $262
2010-03-31 $284
2009-12-31 $302
2009-09-30 $305
2009-06-30 $306
2009-03-31 $303
Sector Industry Market Cap Revenue
Medical MED-DRUGS $5.617B $0.705B
Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $86.949B 32.62
Zoetis (ZTS) US $75.757B 28.27
Takeda Pharmaceutical (TAK) JP $47.602B 9.47
Daiichi Sankyo, - (DSNKY) JP $45.824B 23.49
BeOne Medicines - (ONC) KY $28.015B 0.00
Sandoz Group AG (SDZNY) CH $23.544B 0.00
Merck (MKKGY) DE $16.989B 12.45
Summit Therapeutics (SMMT) US $15.291B 0.00
United Therapeutics (UTHR) US $14.697B 13.00
Shionogi (SGIOY) JP $14.292B 0.00
Neurocrine Biosciences (NBIX) US $12.409B 42.51
IPSEN (IPSEY) FR $10.165B 0.00
Orion OYJ (ORINY) FI $10.083B 27.27
Corcept Therapeutics (CORT) US $7.381B 60.00
Stevanato Group S.p.A (STVN) IT $7.189B 43.96
Madrigal Pharmaceuticals (MDGL) US $6.178B 0.00
Hikma Pharmaceuticals Plc (HKMPF) GB $6.153B 0.00
Grifols, S.A (GRFS) ES $6.064B 0.00
Ono Pharmaceutical (OPHLF) JP $4.913B 14.94
Soleno Therapeutics (SLNO) US $3.805B 0.00
Catalyst Pharmaceuticals (CPRX) US $3.156B 11.06
Crinetics Pharmaceuticals (CRNX) US $3.091B 0.00
Hypermarcas (HYPMY) BR $2.958B 19.46
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.388B 12.91
BioCryst Pharmaceuticals (BCRX) US $2.310B 0.00
NewAmsterdam Pharma (NAMS) NL $2.261B 0.00
Recursion Pharmaceuticals (RXRX) US $2.232B 0.00
Indivior (INDV) US $1.940B 8.23
Dyne Therapeutics (DYN) US $1.671B 0.00
Centessa Pharmaceuticals (CNTA) GB $1.592B 0.00
Evotec AG (EVO) DE $1.438B 0.00
Ocular Therapeutix (OCUL) US $1.437B 0.00
ARS Pharmaceuticals (SPRY) US $1.423B 0.00
Guardian Pharmacy Services (GRDN) US $1.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.107B 22.14
Harrow (HROW) US $1.086B 0.00
Akebia Therapeutics (AKBA) US $1.043B 0.00
Enliven Therapeutics (ELVN) US $1.018B 0.00
Collegium Pharmaceutical (COLL) US $0.970B 5.23
Avadel Pharmaceuticals (AVDL) IE $0.940B 0.00
Ardelyx (ARDX) US $0.880B 0.00
Cronos Group (CRON) CA $0.764B 0.00
Xeris Biopharma Holdings (XERS) US $0.716B 0.00
KalVista Pharmaceuticals (KALV) US $0.714B 0.00
Xencor (XNCR) US $0.687B 0.00
Liminatus Pharma (LIMN) US $0.630B 0.00
Elite Pharmaceuticals (ELTP) US $0.620B 0.00
AleAnna (ANNA) US $0.617B 0.00
Relay Therapeutics (RLAY) US $0.576B 0.00
Regulus Therapeutics (RGLS) US $0.569B 0.00
Theravance Biopharma (TBPH) US $0.563B 0.00
Verve Therapeutics (VERV) US $0.552B 0.00
Bioventus (BVS) US $0.550B 13.94
USANA Health Sciences (USNA) US $0.547B 11.90
Zevra Therapeutics (ZVRA) US $0.506B 0.00
Tourmaline Bio (TRML) US $0.495B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.475B 0.00
Oruka Therapeutics (ORKA) US $0.471B 0.00
Altimmune (ALT) US $0.456B 0.00
Siga Technologies (SIGA) US $0.431B 9.00
Savara (SVRA) US $0.422B 0.00
Organogenesis (ORGO) US $0.384B 0.00
Rigel Pharmaceuticals (RIGL) US $0.384B 10.38
Aquestive Therapeutics (AQST) US $0.354B 0.00
Heron Therapeutics (HRTX) US $0.320B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.298B 0.00
ProKidney (PROK) US $0.286B 0.00
Nature's Sunshine Products (NATR) US $0.266B 24.59
Esperion Therapeutics (ESPR) US $0.242B 0.00
MediWound (MDWD) IL $0.233B 0.00
Nanobiotix S.A (NBTX) FR $0.222B 0.00
4D Molecular Therapeutics (FDMT) US $0.202B 0.00
Lyell Immunopharma (LYEL) US $0.189B 0.00
OmniAb (OABI) US $0.183B 0.00
Journey Medical (DERM) US $0.172B 0.00
Larimar Therapeutics (LRMR) US $0.172B 0.00
Profound Medical (PROF) CA $0.167B 0.00
Aclaris Therapeutics (ACRS) US $0.166B 0.00
Avita Medical (RCEL) US $0.162B 0.00
Enanta Pharmaceuticals (ENTA) US $0.160B 0.00
Aldeyra Therapeutics (ALDX) US $0.159B 0.00
Inhibikase Therapeutics (IKT) US $0.146B 0.00
Korro Bio (KRRO) US $0.137B 0.00
Achieve Life Sciences (ACHV) CA $0.133B 0.00
Lexeo Therapeutics (LXEO) US $0.129B 0.00
Protara Therapeutics (TARA) US $0.129B 0.00
Nektar Therapeutics (NKTR) US $0.124B 0.00
Innate Pharma SA (IPHYF) FR $0.122B 0.00
Wellgistics Health (WGRX) US $0.121B 0.00
Cardiol Therapeutics (CRDL) CA $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.113B 0.00
Cassava Sciences (SAVA) US $0.106B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.098B 0.00
Fractyl Health (GUTS) US $0.097B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Champions Oncology (CSBR) US $0.095B 15.66
VAXART, INC (VXRT) US $0.093B 0.00
Inotiv (NOTV) US $0.092B 0.00
Unicycive Therapeutics (UNCY) US $0.091B 0.00
Arch Biopartners (ACHFF) CA $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.087B 64.67
Nutriband (NTRB) US $0.086B 0.00
Pyxis Oncology (PYXS) US $0.084B 0.00
Galectin Therapeutics (GALT) US $0.084B 0.00
Dominari Holdings (DOMH) US $0.079B 0.00
ESSA Pharma (EPIX) CA $0.076B 0.00
Surrozen (SRZN) US $0.073B 0.00
Vivani Medical (VANI) US $0.068B 0.00
Metagenomi (MGX) US $0.065B 0.00
Telomir Pharmaceuticals (TELO) US $0.064B 0.00
Assertio Holdings (ASRT) US $0.063B 0.00
Context Therapeutics (CNTX) US $0.060B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Prelude Therapeutics (PRLD) US $0.058B 0.00
Gain Therapeutics (GANX) US $0.058B 0.00
Verrica Pharmaceuticals (VRCA) US $0.057B 0.00
NRx Pharmaceuticals (NRXP) US $0.057B 0.00
Century Therapeutics (IPSC) US $0.053B 0.00
PMV Pharmaceuticals (PMVP) US $0.050B 0.00
Rafael Holdings (RFL) US $0.047B 0.00
Avalo Therapeutics (AVTX) US $0.044B 0.00
Mural Oncology (MURA) IE $0.044B 0.00
ElectroCore (ECOR) US $0.043B 0.00
Acrivon Therapeutics (ACRV) US $0.042B 0.00
Iterum Therapeutics (ITRM) IE $0.039B 0.00
Karyopharm Therapeutics (KPTI) US $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.038B 0.00
SCYNEXIS (SCYX) US $0.036B 0.00
PolyPid (PYPD) IL $0.033B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.033B 0.00
Lyra Therapeutics (LYRA) US $0.032B 0.00
FibroGen (FGEN) US $0.032B 0.00
Tempest Therapeutics (TPST) US $0.030B 0.00
Relmada Therapeutics (RLMD) US $0.028B 0.00
Jupiter Neurosciences (JUNS) US $0.026B 0.00
CASI Pharmaceuticals (CASI) CN $0.023B 0.00
Enlivex Therapeutics (ENLV) IL $0.023B 0.00
Natural Alternatives (NAII) US $0.021B 0.00
Mannatech (MTEX) US $0.020B 0.00
BioVie (BIVI) US $0.020B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.020B 0.00
BioLineRx (BLRX) IL $0.019B 0.00
Lipocine (LPCN) US $0.017B 0.00
DURECT (DRRX) US $0.017B 0.00
VYNE Therapeutics (VYNE) US $0.015B 0.00
ProPhase Labs (PRPH) US $0.015B 0.00
TherapeuticsMD (TXMD) US $0.014B 0.00
Phio Pharmaceuticals (PHIO) US $0.014B 0.00
Scienture Holdings (SCNX) US $0.014B 0.00
Ainos (AIMD) US $0.014B 0.00
Cosmos Health (COSM) US $0.014B 0.00
Vivos Therapeutics (VVOS) US $0.013B 0.00
Minerva Neurosciences (NERV) US $0.013B 2.24
GlycoMimetics (GLYC) US $0.013B 0.00
Ernexa Therapeutics (ERNA) US $0.011B 0.00
Addex Therapeutics (ADXN) CH $0.011B 0.00
Mangoceuticals (MGRX) US $0.011B 0.00
Talphera (TLPH) US $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.009B 0.00
Traws Pharma (TRAW) US $0.009B 0.00
SHINECO (SISI) CN $0.009B 0.00
Citius Pharmaceuticals (CTXR) US $0.009B 0.00
Biomerica (BMRA) US $0.009B 0.00
NLS Pharmaceutics (NLSP) CH $0.008B 0.00
Carisma Therapeutics (CARM) US $0.008B 0.00
Nuvilex (PMCB) US $0.007B 0.00
Klotho Neurosciences (KLTO) US $0.007B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.006B 0.00
TransCode Therapeutics (RNAZ) US $0.006B 0.00
Aptorum Group (APM) GB $0.006B 0.00
Plus Therapeutics (PSTV) US $0.006B 0.00
Indaptus Therapeutics (INDP) US $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
Incannex Healthcare (IXHL) AU $0.005B 0.00
Quoin Pharmaceuticals (QNRX) US $0.005B 0.00
Alaunos Therapeutics (TCRT) US $0.005B 0.00
Redhill Biopharma (RDHL) IL $0.005B 0.00
Xenetic Biosciences (XBIO) US $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.004B 0.00
PainReform (PRFX) IL $0.004B 0.00
Jaguar Animal Health (JAGX) US $0.004B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Heatwurx (PCSA) US $0.004B 0.00
CERo Therapeutics Holdings (CERO) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.003B 0.00
InMed Pharmaceuticals (INM) CA $0.003B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Aditxt (ADTX) US $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.003B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
Conduit Pharmaceuticals (CDT) US $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.002B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
MEI Pharma (MEIP) US $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00